Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide

Bone Marrow Transplantation

Volumn 25, Issue 10, 2000, Pages 1087-1092

  Afify, Z ^a   Shaw, P J ^a   Clavano Harding, A ^a   Cowell, C T ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Bone marrow transplantation; Busulfan; Growth; Late effects; Puberty; Thyroid diseases

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; FOLLITROPIN; LUTEINIZING HORMONE; SEX HORMONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CHILD; CHILD GROWTH; CHILDHOOD LEUKEMIA; CLINICAL TRIAL; ENDOCRINE DISEASE; ENDOCRINE FUNCTION; FEMALE; FOLLITROPIN BLOOD LEVEL; GONAD DYSFUNCTION; HORMONE SUBSTITUTION; HUMAN; LONGITUDINAL STUDY; LUTEINIZING HORMONE BLOOD LEVEL; MALE; PREPUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBERTY; SCHOOL CHILD; TESTIS DEVELOPMENT; THYROID DISEASE;

EID: 0034067653     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702384     Document Type: Article

References (21)

1. Cohen A, Rovelli R, Zecca S et al. Endocrine late effects in children who underwent bone marrow transplantation: review. Bone Marrow Transplant 1998; 21 (Suppl. 2): S64-S67.
2. Stevens RF, Hann IM, Wheatley K et al. Marked improvement in outcome with chemotherapy alone in paediatric acute myeloid leukaemia: results of the United Kingdom Medical Research Council's 10th AML trial. BrJHaematol 1998; 101: 130-140.
3. Shaw PJ, Bergin ME, Burgess MA et al. Childhood acute myeloid leukaemia; outcome in a single centre using chemo-therapy and consolidation with busulfan/cyclophosphamide for bone marrow transplantation. J Clin Oncol 1994; 12: 2138-2145.
4. Giorgiani G, Bozzola M, Locatelli F et al. Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. Blood 1995; 86: 825-831.
5. Wingard JR, Plotnick LP, Freemer CS et al. Growth in children after bone marrow transplantation: busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation. Blood 1992; 79: 1068-1073.
6. Michel G, Socié G, Gebhard F et al. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body-irradiation - a report from the Société Française de Greffe de Moelle. J Clin Oncol 1997; 16: 2238-2246.
7. Leahey AM, Teunissen H, Friedman DL et al. Late effects of chemotherapy compared to bone marrow transplantation in the treatment of paediatric acute myeloid leukaemia and myelodysplasia. Med Pediatr Oncol 1999; 32: 163-169.
8. Shaw PJ, Scharping C, Brian RJ et al. Busulfan pharmacokinetics using a single daily high-dose regimen in children with acute leukaemia. Blood 1994; 84: 2357-2362.
9. Goleta-Dy A, Dalla Pozza L, Shaw PJ et al. Acute myeloid leukaemia in Down's syndrome treated by bone marrow transplantation. J Pediatr Child Health 1994; 30: 275-277.
10. Shaw PJ, Afify Z. Rapid tapering of cyclosporin to maximise the graft-versus-Ieukaemia effect. Bone Marrow Transplant 1999; 23: 632-633.
11. Hamill PW, Drizd TA, Johnson CL et al. NCHS growth curves for children from birth to 18 years: United States. DHEW Publ. No (PHS) 78-1650. Vital Health Stats 1977; 165: 1-74.
12. Tanner JM, Whitehouse RH. Clinical longitudinal standards for Ht, weight, Ht velocity, weight velocity, and staees of puberty. Arch Dis Child 1976; 51: 170-179.
13. Shankar SM, Bunin NJ, Moshang T. Growth in children undergoing bone marrow transplantation after busulfan and cyclophosphamide conditioning. J Pediatr Hemaiol Oncol 1996; 18: 362-366.
14. Alter CA, Thornton PS, Willi SM et al. Growth in children after bone marrow transplantation for acute myelogenous leukemia as compared to acute lymphocytic leukemia. J Pediatr Endo Metab 1996; 9: 51-57.
15. De Simone M, Olioso P, Di Bartolomeo P et al. Growth and endocrine function following bone marrow transplantation for thalassemia. Bone Marrow Transplant 1995; 15: 227-233.
16. Guffon N, Souillet G, Maire I et al. Follow-up of nine patients with Hurler syndrome after bone marrow transplantation. J Pediatr 1998; 133: 119-125.
17. Boulad F, Bromley M, Black P et al. Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation. Bone Marrow Transplant 1995; 15: 71-76.
18. Mertens AC, Ramsay NKC, Kouris S, Neglia JP. Patterns of gonadal dysfunction following bone marrow transplantation. Bone Marrow Transplant 1998; 22: 345-350.
19. Thibaud E, Roriguez-Macias K, Tri vin C et al. Ovarian function after bone marrow transplantation during childhood. Bone Marrow Transplant 1998; 21: 287-290.
20. Teinturier C, Hartmann O, Valteau-Couanet D et al. Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure. Bone Marrow Transplant 1998; 22: 989-994.
21. Tiedemann K, Waters KD, Tauro GP et al. Results of intensive therapy in childhood acute myeloid leukaemia, incorporating high-dose melphalan and autologous bone marrow transplantation in first complete remission. Blood 1993; 82: 3730-3738.